These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25559329)

  • 1. Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Anstee QM; Liu YL; Day CP; Reeves HL
    J Hepatol; 2015 Apr; 62(4):982-3. PubMed ID: 25559329
    [No Abstract]   [Full Text] [Related]  

  • 2. HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Krawczyk M; Stokes CS; Romeo S; Lammert F
    J Hepatol; 2015 Apr; 62(4):980-1. PubMed ID: 25559327
    [No Abstract]   [Full Text] [Related]  

  • 3. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
    Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
    J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
    Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
    PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
    Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
    Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S
    J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?
    Goossens N; Hoshida Y
    Gastroenterology; 2016 Jun; 150(8):1710-7. PubMed ID: 26784140
    [No Abstract]   [Full Text] [Related]  

  • 8. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.
    Burza MA; Pirazzi C; Maglio C; Sjöholm K; Mancina RM; Svensson PA; Jacobson P; Adiels M; Baroni MG; Borén J; Ginanni Corradini S; Montalcini T; Sjöström L; Carlsson LM; Romeo S
    Dig Liver Dis; 2012 Dec; 44(12):1037-41. PubMed ID: 22704398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
    Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
    JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.
    Salameh H; Raff E; Erwin A; Seth D; Nischalke HD; Falleti E; Burza MA; Leathert J; Romeo S; Molinaro A; Corradini SG; Toniutto P; Spengler U; Daly A; Day CP; Kuo YF; Singal AK
    Am J Gastroenterol; 2015 Jun; 110(6):846-56. PubMed ID: 25964223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
    Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
    Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
    Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC
    Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.
    Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P
    Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
    Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
    Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.
    Ezzikouri S; Alaoui R; Tazi S; Nadir S; Elmdaghri N; Pineau P; Benjelloun S
    Infect Genet Evol; 2014 Jan; 21():179-83. PubMed ID: 24269995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
    Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.
    Brouwer WP; van der Meer AJ; Boonstra A; Pas SD; de Knegt RJ; de Man RA; Hansen BE; ten Kate FJ; Janssen HL
    Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
    Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW
    Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.